Franzini Andrea, Zekaj Edvin, Bona Alberto, Ciuffi Andrea, Porta Mauro, Servello Domenico
Department of Neurosurgery, Galeazzi Research and Clinical Hospital, Milan, Italy.
Br J Neurosurg. 2023 Aug;37(4):671-674. doi: 10.1080/02688697.2018.1556779. Epub 2019 Jan 25.
We report on a patient, who underwent the resection of a cerebellar primary central nervous system lymphoma and was administered intraoperative fluorescein sodium to improve the visualization of the tumor and guide surgery. Low-dosage fluorescein was administered prior to opening the dura so to distinguish contrast-enhanced lymphomatous tissue from the surrounding unenhanced brain cerebellar parenchyma. Intraoperatively, the tumor was indistinguishable from cerebellar parenchyma under the white light, however, after the administration of low-dose intravenous fluorescein, it appeared brightly fluorescent under yellow light, and was safely resected. Our protocol of administration allowed for the sampling of the pathological tissue while at the same time avoiding neurological damage. The fluorescein-guided technique for the resection of primary central nervous system lymphomas has only been rarely described, as surgical excision of such tumors is rarely indicated. Starting from our case, we review and discuss the pertinent literature. Furthermore, an intraoperative video detail is provided.
我们报告了一例患者,该患者接受了小脑原发性中枢神经系统淋巴瘤切除术,并在术中给予荧光素钠以改善肿瘤可视化并指导手术。在打开硬脑膜之前给予低剂量荧光素,以便将对比增强的淋巴瘤组织与周围未增强的小脑脑实质区分开来。术中,在白光下肿瘤与小脑实质难以区分,然而,在给予低剂量静脉荧光素后,在黄光下它呈现明亮的荧光,并被安全切除。我们的给药方案允许在采样病理组织的同时避免神经损伤。荧光素引导技术用于原发性中枢神经系统淋巴瘤的切除很少被描述,因为此类肿瘤很少需要手术切除。从我们的病例出发,我们回顾并讨论相关文献。此外,还提供了术中视频细节。